← Back to headlines
Mizuho raises Belite Bio price target on Japan drug filing
Mizuho raised its price target for Belite Bio following the company's filing for a new drug in Japan.
9 Sept, 11:46 — 9 Sept, 11:46
Sources
Showing 1 of 1 sources
Mizuho raised its price target for Belite Bio following the company's filing for a new drug in Japan.
